» Articles » PMID: 16455265

DYRK1A BAC Transgenic Mice Show Altered Synaptic Plasticity with Learning and Memory Defects

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2006 Feb 4
PMID 16455265
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Among the various phenotypes seen in Down syndrome (DS), mental retardation is the most common and most debilitating condition suffered by individuals with DS. The DYRK1A gene on human chromosome 21q22.2 encodes a subfamily of protein kinases that displays dual substrate specificities and is known to play a critical role in neurodevelopment. To study DS mental retardation, we have generated transgenic mice that contain only one copy of the complete human DYRK1A gene in a bacterial artificial chromosome. The transgenic mice showed significant impairment in hippocampal-dependent memory tasks in a Morris water maze. Interestingly, we observed shifts in both long-term potentiation and long-term depression, which suggests a role for DYRK1A in bidirectional synaptic plasticity. These mice represent the most clinically relevant DYRK1A mouse model to date and provide us a valuable tool for the in vivo study of mechanisms that underlie the learning and memory deficit in DS.

Citing Articles

DYRK1A Up-Regulation Specifically Impairs a Presynaptic Form of Long-Term Potentiation.

Lepagnol-Bestel A, Haziza S, Viard J, Salin P, Duchon A, Herault Y Life (Basel). 2025; 15(2).

PMID: 40003558 PMC: 11856406. DOI: 10.3390/life15020149.


Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation.

Malueg M, Moo K, Arnett A, Edwards T, Ruskin S, Lambert K Immunohorizons. 2025; 9(1).

PMID: 39846842 PMC: 11841973. DOI: 10.1093/immhor/vlae005.


Regulation of Drosophila brain development and organ growth by the Minibrain/Rala signaling network.

Brown M, Sciascia E, Ning K, Adam W, Veraksa A G3 (Bethesda). 2024; 14(11).

PMID: 39271109 PMC: 11540318. DOI: 10.1093/g3journal/jkae219.


Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine.

Kadyan P, Singh L Pharmacol Rep. 2024; 76(4):665-678.

PMID: 38758470 DOI: 10.1007/s43440-024-00602-8.


Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach.

Haut F, Argyrousi E, Arancio O Int J Mol Sci. 2024; 25(1).

PMID: 38203429 PMC: 10779219. DOI: 10.3390/ijms25010259.